Conversa offers an industry leading Automated Virtual Care and Triage™ platform that enables health systems to remotely monitor, analyze and communicate with patients and healthcare consumers at scale—for chronic care, post acute, perioperative, oncology, OBGYN, prevention and wellness, and many other use cases. The platform automates care where possible, identifies at-risk patients and provides digital triage to higher levels of care for those patients when necessary, e.g., phone calls, telehealth, e-visits or scheduling in-person consults.

Conversa is healthcare’s leader in delivering personalized, automated engagement at scale for patients, members, employees, and consumers. With Conversa Connect™, its proprietary patient profiling and health signals engine, and an extensive library of clinically-intelligent engagement programs, Conversa enables healthcare organizations to effectively and efficiently manage patients across the care continuum. Leading health systems, payers, and pharma companies are using Conversa to develop meaningful relationships and drive better health outcomes at scale. To learn more, visit conversahealth.com, follow @ConversaHealth or text HELLO to 77877.

CB Insights, technology market intelligence company, issued a new report ranking Conversa Health tops (among 200 companies reviewed) in the “leader” category of its analysis of companies providing artificial intelligence-enabled chatbots for self-triage. Conversa scored highest in CB Insights’ analysis on both “ability to execute” and “market strength.” https://conversahealth.com/automated-self-triage/.

With Conversa Connect™, its proprietary patient profiling and health signals engine, and its extensive library of Virtual Care programs, Conversa enables healthcare organizations to serve automated, personalized doctor-patient conversation experiences around chronic condition management, post-hospital discharge, pre- and post-surgery, medication adherence, consumer health education and lifestyle health coaching.

More impactful results than others

• Improved patient satisfaction: 97% of patients feel Amwell-Conversa helps them manage their care
• Better patient engagement: 87% of patient feel more connected with following their care plan
• Reducing procedure show rates: Over 70% reduction in colonoscopy no shows
• Care team satisfaction: 82% of care team members recommend using Amwell-Conversa with their patients
• Reducing hospital readmission: ~32%+ reduction in readmission rates among Medicare patients
• Improved treatment adherence: 89% reduction in premature treatment among cancer patients

And more third party validation than other competing companies https://conversahealth.com/best-remote-diagnostics-company/